Published in Lancet on January 19, 1995
Cu/Zn superoxide dismutase gene mutations in amyotrophic lateral sclerosis: correlation between genotype and clinical features. J Neurol Neurosurg Psychiatry (1996) 1.74
Protein aggregation and protein instability govern familial amyotrophic lateral sclerosis patient survival. PLoS Biol (2008) 1.61
Oxidative stress and superoxide dismutase in development, aging and gene regulation. Age (Omaha) (1998) 0.78
Variants in the ALS2 gene are not associated with sporadic amyotrophic lateral sclerosis. Neurogenetics (2003) 0.76
A mutation in the alpha tropomyosin gene TPM3 associated with autosomal dominant nemaline myopathy. Nat Genet (1995) 2.57
Heterozygous mutations in ANKH, the human ortholog of the mouse progressive ankylosis gene, result in craniometaphyseal dysplasia. Nat Genet (2001) 2.39
Biogenesis of vaccinia: isolation of conditional lethal mutants and electron microscopic characterization of their phenotypically expressed defects. Virology (1978) 2.09
Phorbol ester-induced differentiation permits productive human cytomegalovirus infection in a monocytic cell line. J Immunol (1988) 2.01
Targeted prostate cancer screening in men with mutations in BRCA1 and BRCA2 detects aggressive prostate cancer: preliminary analysis of the results of the IMPACT study. BJU Int (2010) 1.60
A single nucleotide polymorphism in the 5' untranslated region of RAD51 and risk of cancer among BRCA1/2 mutation carriers. Cancer Epidemiol Biomarkers Prev (2001) 1.51
Most germ-line mutations in the nevoid basal cell carcinoma syndrome lead to a premature termination of the PATCHED protein, and no genotype-phenotype correlations are evident. Am J Hum Genet (1997) 1.50
Intention to undergo prophylactic bilateral mastectomy in women at increased risk of developing hereditary breast cancer. J Clin Oncol (2000) 1.45
Linkage of 'pure' autosomal recessive familial spastic paraplegia to chromosome 8 markers and evidence of genetic locus heterogeneity. Hum Mol Genet (1994) 1.29
The spectrum of pathology in central core disease. Neuromuscul Disord (2002) 1.23
Wnt signaling regulates the function of MyoD and myogenin. J Biol Chem (2000) 1.22
Autosomal dominant distal myopathy: linkage to chromosome 14. Am J Hum Genet (1995) 1.22
Macrolide resistance mechanisms among Streptococcus pneumoniae isolated over 6 years of Canadian Respiratory Organism Susceptibility Study (CROSS) (1998 2004). J Antimicrob Chemother (2007) 1.17
Myocyte enhancer factor 2C and Nkx2-5 up-regulate each other's expression and initiate cardiomyogenesis in P19 cells. J Biol Chem (1998) 1.12
Mutation segregation and rapid carrier detection of X-linked muscular dystrophy in dogs. Am J Vet Res (1996) 1.09
In vitro pharmacodynamic modelling simulating free serum concentrations of fluoroquinolones against multidrug-resistant Streptococcus pneumoniae. J Antimicrob Chemother (2001) 1.07
Communication and information-giving in high-risk breast cancer consultations: influence on patient outcomes. Br J Cancer (2004) 1.07
Malignant hyperthermia associated with exercise-induced rhabdomyolysis or congenital abnormalities and a novel RYR1 mutation in New Zealand and Australian pedigrees. Br J Anaesth (2002) 1.06
Biogenesis of poxviruses: role for the DNA-dependent RNA polymerase II of the host during expression of late functions. Proc Natl Acad Sci U S A (1979) 1.05
A mutation in the alpha tropomyosin gene TPM3 associated with autosomal dominant nemaline myopathy NEM1. Nat Genet (1995) 1.05
Botulinum toxin A versus fixed cast stretching for dynamic calf tightness in cerebral palsy. J Paediatr Child Health (1999) 1.05
Myocyte enhancer factor 2C and myogenin up-regulate each other's expression and induce the development of skeletal muscle in P19 cells. J Biol Chem (2000) 1.03
The clinical spectrum of peripheral neuropathies associated with benign monoclonal IgM, IgG and IgA paraproteinaemia. Comparative clinical, immunological and nerve biopsy findings. J Neurol (1991) 1.02
Sorting nexin 3 (SNX3) is disrupted in a patient with a translocation t(6;13)(q21;q12) and microcephaly, microphthalmia, ectrodactyly, prognathism (MMEP) phenotype. J Med Genet (2002) 1.02
Long-term outcomes of genetic counseling in women at increased risk of developing hereditary breast cancer. Patient Educ Couns (2001) 1.01
Two major histocompatibility complex haplotypes influence susceptibility to sporadic inclusion body myositis: critical evaluation of an association with HLA-DR3. Tissue Antigens (2004) 1.01
X-linked myotubular myopathy in a family with three adult survivors. Clin Genet (2003) 1.00
Synergy of an investigational glycopeptide, LY333328, with once-daily gentamicin against vancomycin-resistant Enterococcus faecium in a multiple-dose, in vitro pharmacodynamic model. Antimicrob Agents Chemother (1999) 0.99
Identification of antigenic determinants by polyclonal and hybridoma antibodies induced during the course of infection by vaccinia virus. Virology (1986) 0.98
Bandstab: a PCR-based alternative to cloning PCR products. Biotechniques (1997) 0.98
Nkx2-5 activity is essential for cardiomyogenesis. J Biol Chem (2001) 0.97
A prominent antigenic surface polypeptide involved in the biogenesis and function of the vaccinia virus envelope. Virology (1991) 0.97
Visual field loss associated with vigabatrin: pathological correlations. J Neurol Neurosurg Psychiatry (2001) 0.97
A locus on chromosome 15q for a dominantly inherited nemaline myopathy with core-like lesions. Brain (2003) 0.95
Actin myopathy with nemaline bodies, intranuclear rods, and a heterozygous mutation in ACTA1 (Asp154Asn). Acta Neuropathol (2004) 0.91
Microsatellite instability markers in breast cancer: a review and study showing MSI was not detected at 'BAT 25' and 'BAT 26' microsatellite markers in early-onset breast cancer. Breast Cancer Res Treat (2000) 0.91
Refined localisation of the genes for nebulin and titin on chromosome 2q allows the assignment of nebulin as a candidate gene for autosomal recessive nemaline myopathy. Eur J Hum Genet (1998) 0.90
Assessment of a cytoprotection assay for the discovery and evaluation of anti-human immunodeficiency virus compounds utilizing a genetically-impaired virus. J Virol Methods (1996) 0.89
Factors in serum regulate muscle development in P19 cells. In Vitro Cell Dev Biol Anim (1999) 0.87
Toxic mutants in Charcot's sclerosis. Nature (1995) 0.87
Interaction of an estramustine photoaffinity analogue with cytoskeletal proteins in prostate carcinoma cells. Mol Pharmacol (1994) 0.86
Attitudes to genetic testing for breast cancer susceptibility in women at increased risk developing hereditary breast cancer. J Med Genet (2000) 0.86
Myocyte enhancer factor 2C upregulates MASH-1 expression and induces neurogenesis in P19 cells. FEBS Lett (2000) 0.85
RFLPs of the gene for the human glycine receptor on the X-chromosome. Nucleic Acids Res (1989) 0.84
Attitudes toward prophylactic oophorectomy and screening utilization in women at increased risk of developing hereditary breast/ovarian cancer. Gynecol Oncol (1999) 0.84
Influence of RNA polymerase II upon vaccinia virus-related translation examined by means of alpha-amanitin. Virus Res (1986) 0.83
Ratio of male to female births in the offspring of BRCA1 and BRCA2 carriers. Fam Cancer (2005) 0.83
Adenovirus and adeno-associated virus-mediated delivery of human myophosphorylase cDNA and LacZ cDNA to muscle in the ovine model of McArdle's disease: expression and re-expression of glycogen phosphorylase. Neuromuscul Disord (2008) 0.83
Congenital fibre type disproportion associated with mutations in the tropomyosin 3 (TPM3) gene mimicking congenital myasthenia. Neuromuscul Disord (2010) 0.83
Familial neuronal intranuclear inclusion disease with ubiquitin positive inclusions. J Neurol Sci (1998) 0.82
Butyrycholinesterase K variant and Alzheimer's disease. J Neurol (1999) 0.81
P-glycoprotein binding and modulation of the multidrug-resistant phenotype by estramustine. J Natl Cancer Inst (1994) 0.80
Issues faced by unaffected men with a family history of prostate cancer: a multidisciplinary overview. J Urol (2008) 0.79
Nemaline myopathy with exclusively intranuclear rods and a novel mutation in ACTA1 (Q139H). Neuropediatrics (2007) 0.78
[Myosin storage myopathy: a rare subtype of protein aggregate myopathies]. Fortschr Neurol Psychiatr (2010) 0.78
Autosomal dominant distal myopathy not linked to the known distal myopathy loci. Neuromuscul Disord (1999) 0.78
Factors in serum regulate Nkx2.5 and MEF2C function. In Vitro Cell Dev Biol Anim (2002) 0.78
A polymerase chain reaction screening strategy for the promoter of the canine dystrophin gene. Am J Vet Res (1999) 0.77
40th ENMC Sponsored International Workshop: Nemaline Myopathy. 2-4 February 1996, Naarden, The Netherlands. Neuromuscul Disord (1996) 0.76
Treatment-focused DNA testing for newly diagnosed breast cancer patients: some implications for clinical practice. Clin Genet (2009) 0.76
Estimation of an approximate confidence interval for FRAXA location by using linkage data from many pedigrees. Am J Hum Genet (1991) 0.75
Genetic testing: a round table conversation. Intern Med J (2004) 0.75
Crystallization in suspensions of hard spheres: a Monte Carlo and molecular dynamics simulation study. J Phys Condens Matter (2011) 0.75
Management of MUTYH-associated neoplasia in Australia. Intern Med J (2008) 0.75
Description of hard-sphere crystals and crystal-fluid interfaces: a comparison between density functional approaches and a phase-field crystal model. Phys Rev E Stat Nonlin Soft Matter Phys (2012) 0.75
Diagnostic evaluation and outcome in patients presenting to a casualty department with syncope or presyncope. Aust Clin Rev (1986) 0.75
Genes and brains, molecular medicine and neuropathology. Trends Mol Med (2001) 0.75
The impact of molecular diagnosis on familial colorectal cancer. Clin Chem Lab Med (1998) 0.75
Refinement of the chromosome 5p locus for craniometaphyseal dysplasia. Hum Genet (2001) 0.75
Possible patterns & systems of antenatal care. Personally held case notes. Midwives Chron (1983) 0.75
'Cap myopathy': case report of a family. Neuromuscul Disord (2006) 0.75